NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cybin Inc (NEO: CYBN)

 
CYBN Technical Analysis
1
As on 10th Jul 2024 CYBN STOCK Price closed @ 0.36 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CYBNSTOCK Price

Open 0.36 Change Price %
High 0.36 1 Day N/A N/A
Low 0.35 1 Week 0.00 0.00
Close 0.36 1 Month 0.00 0.00
Volume 88506 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
NEO Canada Most Active Stocks
CCHW 0.51 %
CCHW 0.51 %
GRAM-U 0.32 6.67%
MEDV 0.03 %
MEDI 0.01 -50.00%
CYBN 0.36 %
MMED 14.90 %
ABXX 11.90 %
SLVE 14.89 0.27%
PFU-UN 9.29 0.22%
 
NEO Canada Top Gainers Stocks
GRAM-U 0.32 6.67%
GLDE 17.14 1.72%
CERE-U 9.95 0.30%
SLVE 14.89 0.27%
PUB-UN 13.17 0.23%
PFU-UN 9.29 0.22%
 
NEO Canada Top Losers Stocks
MEDI 0.01 -50.00%
MEDI 0.01 -50.00%
 
 
CYBN
Daily Charts
CYBN
Intraday Charts
Whats New @
Bazaartrend
CYBN
Free Analysis
 
CYBN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
CYBN Forecast July 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
CYBN Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
CYBN Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
CYBN Other Details
Segment EQ
Market Capital 380611200.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CYBN Address
CYBN
 
CYBN Latest News
 
Your Comments and Response on Cybin Inc
 
CYBN Business Profile
Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada. Address: 100 King Street West, Toronto, ON, Canada, M5X 1C9
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service